Trial of PCC Versus FFP in Patients Undergoing Heart Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

January 29, 2020

Study Completion Date

January 29, 2020

Conditions
BleedingSurgeryTransfusion
Interventions
DRUG

Prothrombin Complex Concentrate (PCC)

PCC is a blood product produced through pooling of thousands of human plasmas, which is then treated to inactivate enveloped viruses. From the pooled plasma, vitamin K dependent clotting factors (factors II, VII, IX and X, and protein C and protein S), are selected to produce the concentrated form called PCC.

BIOLOGICAL

Fresh Frozen Plasma

Fresh Frozen Plasma a blood component manufactured from whole blood collection.

Trial Locations (1)

EC1A 7BE

St Bartholomew's Hospital, London

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

lead

Queen Mary University of London

OTHER

NCT03715348 - Trial of PCC Versus FFP in Patients Undergoing Heart Surgery | Biotech Hunter | Biotech Hunter